MDG506 is a novel selective androgen receptor (AR) interaction disruptor that demonstrates low cytotoxicity in prostate cancer (PCa) models and shows a dose-dependent reduction in prostate-specific antigen expression induced by classical antiandrogens.
Molecular Weight:
425.52
CAS Number:
[933005-54-0]
Formula:
C23H24FN3O2S
T202892
* VAT and and shipping costs not included. Errors and price changes excepted
